Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Myelodysplastic Syndrome.

Interferon gamma (IFN-γ) is a cytokine that induces a series of immune responses against viruses and tumors. The pro-apoptotic, anti-tumor and anti-proliferative actions of the cells are ...

In further analyses in mice and human blood cells ... A likely culprit causing Sjögren's disease symptoms in mice: interferon gamma. "It came down to a defect in regulatory T cells and an ...